Cubist Systematic Strategies, LLC Gt Biopharma, Inc. Transaction History

Cubist Systematic Strategies, LLC

  • $15.8 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023
BUY
$0.22 - $0.55 $2,300 - $5,751
10,458 New
10,458 $3,000
Q4 2021

Feb 14, 2022
SELL
$3.05 - $7.08 $102,794 - $238,617
-33,703 Closed
0 $0
Q3 2021

Nov 15, 2021
BUY
$6.68 - $15.26 $225,136 - $514,307
33,703 New
33,703 $227,000

Others Institutions Holding GTBP

# of Institutions
4
Shares Held
564
Call Options Held
0
Put Options Held
0
View Full List

About GT Biopharma, Inc.

GTBP Quotes by TradingView
  • Ticker GTBP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 32,557,700
  • Market Cap $81.7M
  • Description
  • GT Biopharma, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of immuno-oncology products based on its proprietary Tri-specific Killer Engager (TriKE) fusion protein immune cell engager technology platform. It develops GTB-3550, a single-chain tri-specific recombinant fusion protein conjugate th...
More about GTBP
Track This Portfolio

Track Cubist Systematic Strategies, LLC Portfolio

Follow Cubist Systematic Strategies, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email